Plus Therapeutics Income Statement (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)						0.07M	0.13M	0.50M	1.90M	1.24M	1.31M	1.68M	1.28M	1.46M	1.41M	1.06M	1.39M	1.40M	1.37M	1.03M
Cost of Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)	1.11M	1.49M	1.60M	1.78M	2.83M	2.94M	2.14M	2.98M	1.42M	2.49M	0.07M	2.76M	2.77M	2.86M	2.19M	1.76M	1.25M	2.44M	2.94M	2.87M
Selling, General & Administrative (Quarter)	1.47M	1.99M	2.04M	2.14M	2.29M	2.22M	3.58M	2.25M	1.92M	2.00M	2.38M	2.21M	2.20M	2.40M	3.13M	2.84M	1.68M	3.44M	4.17M	5.28M
Other Operating Expenses (Quarter)		-0.02M	-0.05M					-0.00M			2.72M
Operating Expenses (Quarter)	2.58M	3.50M	3.94M	3.93M	5.12M	5.17M	5.72M	5.23M	3.34M	4.49M	5.17M	4.98M	4.98M	5.25M	5.31M	4.59M	2.93M	5.88M	7.11M	8.15M
Operating Income (Quarter)	-2.58M	-3.50M	-3.94M	-3.93M	-5.12M	-5.09M	-5.57M	-4.72M	-1.49M	-3.25M	-3.86M	-3.30M	-3.70M	-3.80M	-3.90M	-3.54M	-1.54M	-4.48M	-5.74M	-7.12M
EBIT (Quarter)	-2.58M	-3.50M	-3.94M	-3.93M	-5.12M	-5.09M	-5.57M	-4.72M	-1.49M	-3.25M	-3.86M	-3.30M	-3.70M	-3.80M	-3.90M	-3.54M	-1.54M	-4.48M	-5.74M	-7.12M
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)	0.00M	0.01M	0.01M	0.01M	0.02M	0.05M	0.07M	0.05M	0.12M	0.12M	0.11M	0.07M	0.07M	0.08M	0.05M	0.00M	0.03M	0.06M	0.03M	0.19M
Other Non Operating Income (Quarter)		0.00M	0.00M	0.00M
Non Operating Income (Quarter)	-0.23M	-0.23M	-0.22M	-0.19M	-0.16M	-0.12M	-0.09M	-0.08M	0.01M	0.03M	0.05M	0.04M	0.76M	0.93M	-0.00M	-13.87M	6.69M	0.06M	0.03M	0.17M
Net income details
EBT (Quarter)	-2.80M	-3.69M	-3.44M	-4.12M	-5.30M	-5.22M	-5.66M	-4.77M	-2.73M	-3.22M	-3.96M	-3.26M	-3.66M	-3.78M	-3.99M	-4.08M	-1.51M	-4.42M	-5.23M	-6.95M
Profit After Tax (Quarter)	-2.80M	-3.72M	-4.16M	-4.12M	-5.28M	-5.22M	-5.66M	-4.80M	-1.48M	-3.22M	-3.81M	-3.26M	-2.94M	-2.87M	-3.90M	-17.40M	5.15M	-4.42M	-5.73M	-6.95M
Income from Continuing Operations (Quarter)	-2.80M	-3.69M	-3.44M	-4.12M	-5.30M	-5.22M	-5.66M	-4.77M	-2.73M	-3.22M	-3.96M	-3.26M	-3.66M	-3.78M	-3.99M	-4.08M	-1.51M	-4.42M	-5.23M	-6.95M
Consolidated Net Income (Quarter)	-2.80M	-3.69M	-3.44M	-4.12M	-5.30M	-5.22M	-5.66M	-4.77M	-2.73M	-3.22M	-3.96M	-3.26M	-3.66M	-3.78M	-3.99M	-4.08M	-1.51M	-4.42M	-5.23M	-6.95M
Income towards Parent Company (Quarter)	-2.80M	-3.69M	-3.44M	-4.12M	-5.30M	-5.22M	-5.66M	-4.77M	-2.73M	-3.22M	-3.96M	-3.26M	-3.66M	-3.78M	-3.99M	-4.08M	-1.51M	-4.42M	-5.23M	-6.95M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-2.80M	-3.69M	-3.44M	-4.12M	-5.30M	-5.22M	-5.66M	-4.77M	-2.73M	-3.22M	-3.96M	-3.26M	-3.66M	-3.78M	-3.99M	-4.08M	-1.51M	-4.42M	-5.23M	-6.95M
Additional items
EPS (Basic) (Quarter)	-92.90	-104.38	-106.62	-71.78	-89.28	-71.28	-80.77	-51.39	-27.23	-24.95	-31.50	-18.86	-14.06	-12.04	-15.03	-7.01	-0.78	-1.03	-1.68	-1.05
EPS (Diluted) (Quarter)	-92.90	-104.38	-106.62	-71.78	-89.28	-71.28	-80.77	-51.39	-27.23	-24.95	-31.50	-18.86	-8.51	-12.04	-12.96	-7.01	-0.18	-1.03	-1.68	-1.05
Shares Outstanding (Quarter)	0.03M	0.04M	0.03M	0.06M	0.06M	0.07M	0.07M	0.09M	0.10M	0.13M	0.13M	0.17M	0.26M	0.31M	0.27M	0.58M	1.94M	4.30M	3.11M	6.65M
Shares Outstanding (Diluted) (Quarter)	0.03M	0.04M	0.03M	0.06M	0.06M	0.07M	0.07M	0.09M	0.10M	0.13M	0.13M	0.17M	0.43M	0.31M	0.31M	0.58M	8.37M	4.30M	3.11M	6.65M
Shares Outstanding (Entity) (Quarter)	0.03M	0.04M	0.03M	0.06M	0.06M	0.09M	0.07M	0.10M	0.12M	0.13M	0.13M	0.18M	0.24M	0.31M	0.25M	0.69M	1.94M	4.30M	3.11M	6.87M
EBITDA (Quarter)	-2.58M	-3.50M	-3.94M	-3.93M	-5.12M	-5.09M	-5.57M	-4.72M	-1.49M	-3.25M	-3.86M	-3.30M	-3.70M	-3.80M	-3.90M	-3.54M	-1.54M	-4.48M	-5.74M	-7.12M
Interest Expenses (Quarter)	0.23M	0.20M	-0.49M	0.20M	0.20M	0.17M	0.16M	0.10M	1.36M	0.09M	0.21M	0.03M	0.03M	0.06M	0.15M	0.55M		0.00M	-0.48M	0.02M

Research Tools

Datasets

Plans

Developers

Cerenome PSTV Income Statement (2010-2026)

Research Tools

Datasets

Plans

Developers

Cerenome PSTV Income Statement (2010-2026)

Create an account

Sign In

Reset Password